Priorities & Actions
Parkinson's Plan 2006
Parkinson's Matrix
Research Agenda
Research Resources
Animal Models
Antibody Resources
Clinical Research
Gene Therapy
Genetic Resources
Brain Banks Across the
United States
Funding Research
Funding Announcements
Clinical Trials
Related Literature
Research Centers
NIH Intramural Research
Udall Centers of |
Excellence |
Patient/Caregiver Information
Parkinson's Disease
PD Clinical Trials
NINDS is part of the
National Institutes of
Health
Join our electronic mailing list
The central goal of the Northwestern University Udall Center is to determine how neural activity in basal ganglia circuits is altered in Parkinson's disease, with the goal of developing new therapies to normalize this activity and alleviate the symptoms of the disease.
The center's research program employs state-of-the-art electrophysiological, optical and computational approaches to understand the pathophysiology of the basal ganglia regions most intimately linked to the symptoms of Parkinson's disease - the globus pallidus and subthalamic nucleus. Current neurosurgical treatment strategies for later stage Parkinson's disease patient target these regions, most commonly with deep brain stimulation.
The Northwestern University Udall Center has four project teams and a molecular biology core facility. Surmeier directs one of the project teams studying neurons found in the globus pallidus. Mark Bevan, associate professor of physiology, heads a team studying neurons found in the subthalamic nucleus.
Two other projects involve researchers affiliated with other institutions. Kitoshi Kita, University of Tennessee Health Sciences Center, Memphis, heads a team whose goal is to understand how globus pallidus and subthalamic neurons communicate with one another. Last, Charles Wilson, University of Texas, San Antonio, directs a project aimed at generating computational models of how these complex brain circuits interact in Parkinson's disease.
Last updated April 11, 2005